Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Kyverna Therapeutics Inc have a median target of 40.00, with a high estimate of 48.00 and a low estimate of 7.00. The median estimate represents a 656.14% increase from the last price of 5.29.
High | 807.4% | 48.00 |
Med | 656.1% | 40.00 |
Low | 32.3% | 7.00 |
Earnings history & estimates in USD
Average growth rate | +68.00% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼